| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/11/2023 | 284.62% | HC Wainwright & Co. | $9 → $10 | Maintains | Buy |
| 07/03/2023 | 246.15% | HC Wainwright & Co. | $10 → $9 | Maintains | Buy |
| 03/21/2023 | 284.62% | HC Wainwright & Co. | → $10 | Reiterates | → Buy |
| 09/26/2022 | 284.62% | HC Wainwright & Co. | $9 → $10 | Maintains | Buy |
| 07/25/2022 | 246.15% | HC Wainwright & Co. | $11 → $9 | Maintains | Buy |
| 03/22/2022 | 323.08% | HC Wainwright & Co. | $14 → $11 | Maintains | Buy |
| 03/17/2021 | 438.46% | HC Wainwright & Co. | $15 → $14 | Maintains | Buy |
| 01/04/2021 | 476.92% | HC Wainwright & Co. | $20 → $15 | Maintains | Buy |
| 09/30/2020 | 669.23% | HC Wainwright & Co. | $18 → $20 | Maintains | Buy |
| 05/26/2020 | 592.31% | HC Wainwright & Co. | $26 → $18 | Maintains | Buy |
| 05/15/2020 | 284.62% | B. Riley Securities | $12 → $10 | Maintains | Buy |
| 03/30/2020 | 900% | HC Wainwright & Co. | $23 → $26 | Reiterates | → Buy |
| 01/28/2020 | 784.62% | HC Wainwright & Co. | $21 → $23 | Reiterates | → Buy |
| 10/23/2019 | 707.69% | HC Wainwright & Co. | $18 → $21 | Reiterates | → Buy |
| 09/20/2019 | 419.23% | B. Riley Securities | → $13.5 | Initiates Coverage On | → Buy |
| 06/10/2019 | 476.92% | HC Wainwright & Co. | → $15 | Initiates Coverage On | → Buy |
What is the target price for Eton Pharmaceuticals (ETON)?
The latest price target for Eton Pharmaceuticals (NASDAQ: ETON) was reported by HC Wainwright & Co. on August 11, 2023. The analyst firm set a price target for $10.00 expecting ETON to rise to within 12 months (a possible 284.62% upside). 4 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Eton Pharmaceuticals (ETON)?
The latest analyst rating for Eton Pharmaceuticals (NASDAQ: ETON) was provided by HC Wainwright & Co., and Eton Pharmaceuticals maintained their buy rating.
When is the next analyst rating going to be posted or updated for Eton Pharmaceuticals (ETON)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Eton Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Eton Pharmaceuticals was filed on August 11, 2023 so you should expect the next rating to be made available sometime around August 11, 2024.
Is the Analyst Rating Eton Pharmaceuticals (ETON) correct?
While ratings are subjective and will change, the latest Eton Pharmaceuticals (ETON) rating was a maintained with a price target of $9.00 to $10.00. The current price Eton Pharmaceuticals (ETON) is trading at is $2.60, which is out of the analyst's predicted range.